微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 0.17% | -81.32% | -51.43% | 114/159 | 4.21% | 迪哲医药 | 115.44% | 行业排名> |
| 2026-06-30 | 0.35% | -38.6% | 66.67% | 109/159 | 1.36% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | 0.21% | -44.74% | -72.37% | 116/159 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | 0.76% | -47.95% | -16.48% | 99/159 | -4.32% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | 0.91% | -45.83% | 59.65% | 102/159 | 1.69% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 0.57% | -45.71% | 50% | 101/159 | 0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 0.38% | -45.71% | -73.97% | 102/159 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 1.46% | -10.98% | -13.1% | 94/159 | -9.4% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 1.68% | -41.67% | 60% | 101/159 | 4.26% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 1.05% | -48.53% | 50% | 102/159 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 0.7% | -19.54% | -57.32% | 100/159 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 1.64% | -59.1% | -43.06% | 93/159 | -0.94% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 2.88% | -37.12% | 41.18% | 93/159 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 2.04% | -25.27% | 134.48% | 82/159 | 1.49% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.87% | -32.03% | -78.3% | 96/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 4.01% | -1.96% | -12.45% | 82/159 | 0.84% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 4.58% | 40.06% | 67.77% | 68/159 | 2.87% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 2.73% | 20.26% | 113.28% | 73/159 | 2.21% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.28% | -20% | -68.7% | 80/159 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 4.09% | -44.05% | 25.08% | 83/159 | 0.87% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 3.27% | -47.26% | 44.05% | 94/159 | 4.45% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 2.27% | -48.87% | 41.88% | 93/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.6% | -16.67% | -78.11% | 75/159 | 2.48% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 7.31% | -19.58% | 17.9% | 73/159 | 3.82% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 6.2% | -18.31% | 39.64% | 64/159 | 3.15% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 4.44% | -9.76% | 131.25% | 61/159 | 4.28% | 中哲精化 | 45.32% | 行业排名> |
| 2020-03-31 | 1.92% | 1.05% | -78.88% | 49/159 | 2.23% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 9.09% | 18.21% | 19.76% | 62/159 | 2.62% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 7.59% | 9.52% | 54.27% | 48/159 | 7.58% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 4.92% | 21.18% | 158.95% | 48/159 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.9% | 0.53% | -75.29% | 59/159 | 2.44% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 7.69% | 1.85% | 10.97% | 67/159 | 7.16% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 6.93% | 1.17% | 70.69% | 46/159 | 7.2% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 4.06% | -2.17% | 114.81% | 55/159 | 4.62% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1.89% | -25% | -74.97% | 58/159 | 2.57% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 7.55% | -41.11% | 10.22% | 70/159 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 6.85% | -34.07% | 65.06% | 48/159 | 8.3% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 4.15% | -37.5% | 64.68% | 59/159 | 5.55% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 2.52% | -23.64% | -80.34% | 35/159 | 2.11% | 中哲精化 | 54.24% | 行业排名> |
| 2016-12-31 | 12.82% | -19.52% | 23.39% | 40/159 | 6.11% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 10.39% | 2% | 56.48% | 23/159 | 5.7% | ST南新 | 81.7% | 行业排名> |
| 2016-06-30 | 6.64% | 2% | -58.32% | 28/159 | 3.56% | 德展健康 | 29.5% | 行业排名> |